Beauty Health Co (SKIN) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Beauty Health Co stock (SKIN) is currently trading at $1.10. Beauty Health Co PS ratio (Price-to-Sales) is 0.49. Analyst consensus price target for SKIN is $1.69. WallStSmart rates SKIN as Sell.
- SKIN PE ratio analysis and historical PE chart
- SKIN PS ratio (Price-to-Sales) history and trend
- SKIN intrinsic value — DCF, Graham Number, EPV models
- SKIN stock price prediction 2025 2026 2027 2028 2029 2030
- SKIN fair value vs current price
- SKIN insider transactions and insider buying
- Is SKIN undervalued or overvalued?
- Beauty Health Co financial analysis — revenue, earnings, cash flow
- SKIN Piotroski F-Score and Altman Z-Score
- SKIN analyst price target and Smart Rating
Beauty Health Co
📊 No data available
Try selecting a different time range
Smart Analysis
Beauty Health Co (SKIN) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, institutional own.. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Beauty Health Co (SKIN) Key Strengths (3)
Growing significantly faster than its price suggests
Paying less than $1 for every $1 of annual revenue
90.39% of shares held by major funds and institutions
Supporting Valuation Data
Beauty Health Co (SKIN) Areas to Watch (6)
Company is destroying shareholder value
Revenue declining -1.40%, a shrinking business
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Micro-cap company with very limited liquidity and high volatility
Fairly priced relative to book value
Supporting Valuation Data
Beauty Health Co (SKIN) Detailed Analysis Report
Overall Assessment
This company scores 41/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.95), Price/Sales (0.49) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Some valuation metrics including Price/Book (2.33) suggest expensive pricing. Growth concerns include Revenue Growth at -1.40%, which may limit upside. Profitability pressure is visible in Return on Equity at -16.90%, Operating Margin at 0.20%, Profit Margin at -3.17%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -16.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SKIN Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SKIN's Price-to-Sales ratio of 0.49x sits near its historical average of 0.47x (71th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 3% below its historical high of 0.51x set in Mar 2026, and 12% above its historical low of 0.44x in Mar 2026. Over the past 12 months, the PS ratio has expanded from ~0.4x, reflecting growing market expectations outpacing revenue growth.
Compare SKIN with Competitors
Top HOUSEHOLD & PERSONAL PRODUCTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Beauty Health Co (SKIN) · CONSUMER DEFENSIVE › HOUSEHOLD & PERSONAL PRODUCTS
The Big Picture
Beauty Health Co is in a turnaround phase, with management focused on restoring profitability. Revenue reached 301M with 1% decline year-over-year. The company is currently unprofitable, posting a -3.2% profit margin.
Key Findings
Generating 14M in free cash flow and 15M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -3.2% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive moves, and regulatory changes that could impact Beauty Health Co.
Bottom Line
Beauty Health Co is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Beauty Health Co(SKIN)
NASDAQ
CONSUMER DEFENSIVE
HOUSEHOLD & PERSONAL PRODUCTS
USA
Edge Systems, LLC designs, develops, manufactures, markets and sells aesthetic products and technologies. The company is headquartered in Signal Hill, California with a location in Long Beach, California.